SUBSCRIBE
SUBSCRIBE

Septerna, Inc.

NEWS
Business
Top Life Sciences Startups to Watch in 2023
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.
December 5, 2022
 · 
15 min read
 · 
BioSpace Editorial Staff
Biotech Bay
Genetown and Biotech Bay Reel in Series A Funds in 2022
After reaching a record high in 2021, venture capital dollars have tailed off in the biopharma industry in 2022. That said, a few biopharma hotbeds have still seen sizeable launch rounds.
November 2, 2022
 · 
5 min read
 · 
Heather McKenzie
IN THE PRESS
Press Releases
Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering
October 31, 2024
 · 
2 min read
Press Releases
Septerna Prices Upsized Initial Public Offering
October 25, 2024
 · 
4 min read
Press Releases
Septerna Presents New Preclinical Data at ASBMR 2024 Highlighting Therapeutic Potential of Oral Small Molecule Parathyroid Hormone 1 Receptor (PTH1R) Agonists for Hypoparathyroidism
September 30, 2024
 · 
3 min read
Biotech Bay
Septerna to Participate in the Jefferies Global Healthcare Conference
May 28, 2024
 · 
1 min read
Biotech Bay
Septerna to Present Preclinical Data from GPCR Drug Discovery Engine at ENDO 2024
May 20, 2024
 · 
4 min read
Biotech Bay
Septerna to Participate in Upcoming Investor and Industry Conferences
February 22, 2024
 · 
1 min read
Deals
Septerna Announces Novel GPCR-targeted Program Acquired by Vertex
September 12, 2023
 · 
3 min read
Business
Septerna Bolsters Leadership Team as the Company Advances its Multi-Product Pipeline Toward Clinical Studies
August 31, 2023
 · 
5 min read
Biotech Bay
Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines
July 11, 2023
 · 
5 min read
Business
Septerna Announces the Formation of a Cross-Functional Scientific and Drug Discovery Advisory Board
December 19, 2022
 · 
6 min read
AWARDS
  • NextGen Class of 2023
JOBS